HX7-28584-99617
3 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 563 / MN
- Registered
- 2021-11-17
- Relationship
- Child or adolescent in my care
- Guardian
- 3RR-10858-74965
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-28
Dose 1 — Pfizer-BioNTech
-
2021-06-18
Dose 2 — Pfizer-BioNTech
-
2021-11-17
Registered in v-safe
- 2021-12-17
-
2022-01-08
Dose 3 — Pfizer-BioNTech
-
2022-01-10
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
- 2022-01-11
- 2022-01-12
- 2022-01-14
- 2022-01-15
- 2022-01-22
- 2022-01-29
- 2022-02-05
-
2022-02-12
Survey response — day 35, dose 3, dependentMedDRA: Decreased appetite, Rhinorrhoea, Sneezing — Feeling: FairFree text: Brady has a runny nose, sneezing and loss of appetite yesterday and today. He has been resting in bed.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-19
- 2022-04-09
- 2022-07-09
- 2023-01-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-28 | Pfizer-BioNTech | No |
| 2 | 2021-06-18 | Pfizer-BioNTech | No |
| 3 | 2022-01-08 | Pfizer-BioNTech | No |
Free text
Release 11 — day 35, dose 3, dependent
Symptoms: Brady has a runny nose, sneezing and loss of appetite yesterday and today. He has been resting in bed.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Decreased appetite | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release